Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 21:6:e06.
doi: 10.15420/cfr.2019.12. eCollection 2020 Mar.

Telemonitoring in Heart Failure Management

Affiliations
Review

Telemonitoring in Heart Failure Management

Ivo Planinc et al. Card Fail Rev. .

Abstract

Telemonitoring (TM) aims to predict and prevent worsening heart failure (HF) episodes and improve self-care, patient education, treatment adherence and survival. There is a growing number of TM options for patients with HF, but there are numerous challenges in reaching positive outcomes. Conflicting evidence from clinical trials may be the result of the enormous heterogeneity of TM devices tested, differences in selected patient populations and variabilities between healthcare systems. This article covers some basic concepts of TM, looking at the recent advances in the most frequently used types of TM and the evidence to support its use in the care of people with HF.

Keywords: Telemonitoring; cardiac implantable electronic device; heart failure; left ventricular assist device; pulmonary artery pressure monitoring; remote patient monitoring; structured telephone support.

PubMed Disclaimer

Conflict of interest statement

Disclosure: IP has received personal fees and non-financial support related to travel from Novartis, Pfizer, Boehringer-Ingelheim, Teva Pharmaceutical Industries, Berlin-Chemie Menarini, PharmaS, Sanofi, Bayer, Krka and Servier. DM has received personal fees from Abbott, Novartis, Roche diagnostics, Bayer, Pfizer, Boehringer Ingelheim, Amgen, Sanofi and Krka. MC has received grants, personal fees and non-financial support related to travel from Novartis, GE Healthcare, Abbott, Roche Diagnostics, Bayer, Pfizer, Boehringer-Ingelheim, Berlin-Chemie Menarini, Servier, Corvia, AstraZeneca, Sanofi Genzyme, Sandoz, Amgen, Teva Pharmaceutical Industries and Orion Pharma.

References

    1. Benjamin EJ, Muntner P, Alonso A et al. AHA statistical update: heart disease and stroke statistics – 2019 update. A report from the American Heart Association. Circulation. 2019;139:e56–528. doi: 10.1161/CIR.00000000000. - DOI - PubMed
    1. Bello NA, Claggett B, Desai AS et al. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ Heart Fail. 2014;7:590–5. doi: 10.1161/CIRCHEARTFAILURE.113.001281. - DOI - PMC - PubMed
    1. Dunlay SM, Redfield MM, Weston SA et al. Hospitalizations after heart failure diagnosis: a community perspective. J Am Coll Cardiol. 2009;54:1695–702. doi: 10.1016/j.jacc.2009.08.019. - DOI - PMC - PubMed
    1. Sueta CA, Rodgers JE, Chang PP et al. Medication adherence based on part D claims for patients with heart failure after hospitalization (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2015;116:413–9. doi: 10.1016/j.amjcard.2015.04.058. - DOI - PMC - PubMed
    1. Adamson PB. Pathophysiology of the transition from chronic compensated to acute decompensated heart failure: New insights from continuous monitoring devices. Curr Heart Fail Rep. 2009;6:287. doi: 10.1007/s11897-009-0039-z. - DOI - PubMed